52333-42-3 Usage
Description
7-Bromopyrido[2,3-b]pyrazine is a heterocyclic aromatic compound with the molecular formula C8H5BrN4. It features a pyrido[2,3-b]pyrazine ring system with a bromine atom attached at the 7th position, making it a valuable intermediate in various chemical syntheses.
Uses
Used in Pharmaceutical Industry:
7-Bromopyrido[2,3-b]pyrazine is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structural properties and ability to interact with biological systems make it a promising candidate for the development of new drugs.
Used in Agrochemical Industry:
7-Bromopyrido[2,3-b]pyrazine is also utilized as an intermediate in the production of agrochemicals, contributing to the development of effective pesticides and other agricultural chemicals.
Used in Organic Electronic Materials:
7-Bromopyrido[2,3-b]pyrazine is employed in the development of organic electronic materials, such as organic light-emitting diodes (OLEDs) and organic solar cells, due to its electronic properties and potential for molecular design.
Used in Organic Chemistry:
As a building block in organic chemistry, 7-Bromopyrido[2,3-b]pyrazine is used for the synthesis of various complex organic molecules, enabling the creation of novel compounds with diverse applications.
Due to its diverse applications, 7-Bromopyrido[2,3-b]pyrazine is of significant interest to researchers and industries in the fields of pharmaceuticals, agrochemicals, and organic materials.
Check Digit Verification of cas no
The CAS Registry Mumber 52333-42-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,3,3 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 52333-42:
(7*5)+(6*2)+(5*3)+(4*3)+(3*3)+(2*4)+(1*2)=93
93 % 10 = 3
So 52333-42-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrN3/c8-5-3-6-7(11-4-5)10-2-1-9-6/h1-4H
52333-42-3Relevant articles and documents
FUSED PYRAZINE DERIVATIVES AS KINASE INHIBITORS
-
Page/Page column 41-42, (2010/06/11)
A series of quinoxaline derivatives, and analogues thereof, which are functionalised further by a substituted phenyl or pyridinyl moiety, being selective inhibitors of PO kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.